| Date Filed | Type | Description |
| 08/14/2023 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
| 06/10/2022 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 90,000 options to buy
@ $0.27, valued at
$24.3k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Huang Alice Shih-hou (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 80,000 options to buy
@ $1.55, valued at
$124k
|
|
| 06/19/2020 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 23,250 options to buy
@ $0.88, valued at
$20.5k
|
|
| 10/15/2019 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 46,500 options to buy
@ $0.64, valued at
$29.8k
|
|
| 04/04/2019 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 78,287 shares
@ $5.85, valued at
$458k
Disposed/sold 3,058 options to buy
@ $1.48, valued at
$4.5k
Disposed/sold 4,281 options to buy
@ $1.23, valued at
$5.3k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 01/07/2019 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 11/13/2018 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 40,339 shares
@ $0
Disposed/sold 10,625 options to buy
@ $4.56, valued at
$48.5k
Disposed/sold 1,875 options to buy
@ $4.56, valued at
$8.6k
Disposed/sold 625 options to buy
@ $4.56, valued at
$2.9k
Disposed/sold 1,458 options to buy
@ $4.56, valued at
$6.6k
Disposed/sold 625 options to buy
@ $20.88, valued at
$13.1k
Disposed/sold 1,458 options to buy
@ $20.88, valued at
$30.4k
Disposed/sold 625 options to buy
@ $31.92, valued at
$20k
Disposed/sold 1,458 options to buy
@ $31.92, valued at
$46.5k
Disposed/sold 416 options to buy
@ $111.84, valued at
$46.5k
Disposed/sold 1,458 options to buy
@ $111.84, valued at
$163.1k
|
|
| 06/05/2018 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 55,000 options to buy
@ $0.73, valued at
$40.2k
|
|
| 05/21/2018 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 75,000 options to buy
@ $0.71, valued at
$53.3k
|
|
| 05/01/2018 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 1,127 shares
@ $0 |
|
| 01/08/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2017 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 60,674 shares
@ $0.89, valued at
$54k
|
|
| 06/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2017 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.45, valued at
$43.5k
|
|
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Immune Design Corp. |
| 06/03/2016 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 36,620 options to buy
@ $6.2, valued at
$227k
|
|
| 05/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2016 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Sold 3,312 shares
@ $157.2113, valued at
$520.7k
|
|
| 03/31/2016 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 1,688 shares
@ $149.49, valued at
$252.3k
Exercised 5,000 options to buy
@ $50.44, valued at
$252.2k
|
|
| 08/30/2013 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Sold 4,582 shares
@ $109.66, valued at
$502.5k
Gifted 910 shares
@ $0 |
|
| 03/01/2013 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 4,114 shares
@ $91.03, valued at
$374.5k
Sold 886 shares
@ $92.94, valued at
$82.3k
Exercised 5,000 options to buy
@ $74.89, valued at
$374.5k
|
|
| 10/04/2012 |
3
| BALTIMORE DAVID (Director) has filed a Form 3 on Regulus Therapeutics Inc. |
| 05/01/2012 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 1,395 shares
@ $0
Granted 5,000 options to buy
@ $71.64, valued at
$358.2k
|
|
| 03/12/2012 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 4,378 shares
@ $66.95, valued at
$293.1k
Exercised 5,000 options to buy
@ $58.61, valued at
$293.1k
|
|
| 12/22/2011 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Paid exercise price by delivering 14,267 shares
@ $63.14, valued at
$900.8k
Exercised 16,000 options to buy
@ $56.3, valued at
$900.8k
|
|
| 04/27/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/28/2010 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 1,711 shares
@ $0
Granted 5,000 options to buy
@ $58.43, valued at
$292.2k
|
|
| 04/29/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 12/05/2008 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on AMGEN INC |